Caribou Biosciences Inc CRBU:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/16/24 EDT
3.59quote price arrow down-0.05 (-1.37%)
Volume
1,733,735
52 week range
3.44 - 8.59
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.59
  • 52 Week High8.59
  • 52 Week High Date07/12/23
  • 52 Week Low3.44
  • 52 Week Low Date05/08/24

Key Stats

  • Market Cap324.241M
  • Shares Out90.32M
  • 10 Day Average Volume1.82M
  • Dividend-
  • Dividend Yield-
  • Beta2.56
  • YTD % Change-36.47

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.59
  • 52 Week High8.59
  • 52 Week High Date07/12/23
  • 52 Week Low3.44
  • 52 Week Low Date05/08/24
  • Market Cap324.241M
  • Shares Out90.32M
  • 10 Day Average Volume1.82M
  • Dividend-
  • Dividend Yield-
  • Beta2.56
  • YTD % Change-36.47

RATIOS/PROFITABILITY

  • EPS (TTM)-1.45
  • P/E (TTM)-2.47
  • Fwd P/E (NTM)-1.88
  • EBITDA (TTM)-127.278M
  • ROE (TTM)-37.09%
  • Revenue (TTM)33.404M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-345.05%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/17/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Caribou Biosciences Inc

 

Profile

MORE
Caribou Biosciences, Inc. is a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It is engaged in developing transformative therapies for patients with devastating diseases. Its genome-editing platform, including its Cas12a chRDNA technology, enables precision to develop cell therapies that are armored to potentially improve antitumor activity. Its pipeline includes three clinical-stage allogeneic cell...
Andrew Guggenhime
Independent Chairman of the Board
Rachel Haurwitz Ph.D.
President, Chief Executive Officer, Co-Founder, Director
Jason O'byrne
Chief Financial Officer
Tim Kelly
Chief Technology Officer
Address
2929 7TH STREET, STE 120
Berkeley, CA
94710
United States

Top Peers

SYMBOLLASTCHG%CHG
MRSN
Mersana Therapeutics Inc
2.58+0.01+0.39%
FHTX
Foghorn Therapeutics Inc.
5.81+0.52+9.83%
RNAC
Cartesian Therapeutics Inc
26.34-0.31-1.16%
MGTX
MeiraGTx Holdings PLC
5.68+0.15+2.71%
PGEN
Precigen Inc
1.40-0.04-2.78%